Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

10. November 2025 08:30 ET | Quelle: Myriad Genetics, Inc.

Myriad Genetics Adds 15 Clinically Actionable Genes to MyRisk® Hereditary Cancer Test to Support Evolving Clinical Needs

Myriad Genetics expanded MyRisk® Hereditary Cancer Test to include genes referenced in national oncology guidelines.
16. Oktober 2024 09:00 ET | Quelle: Myriad Genetics, Inc.

Myriad Genetics and jscreen™ Announce Strategic Partnership to Advance Health Equity and Genetic Testing Access

Myriad Genetics announced a strategic partnership with jscreen to advance health equity and genetic testing access.
15. Februar 2024 16:05 ET | Quelle: Myriad Genetics, Inc.

Myriad Genetics Appoints Dallas Reed, MD, FACOG, FACMG as Principal Medical Advisor of Women’s Health

SALT LAKE CITY, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced the appointment of Dallas Reed, MD,...
06. September 2023 07:00 ET | Quelle: Myriad Genetics, Inc.

New Myriad Genetics Survey Reveals Widespread Confusion and Misconceptions About Ovarian Cancer Screening Among a Majority of Women

SALT LAKE CITY, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in genetic testing and precision medicine, today revealed new nationwide survey results indicating...
06. August 2019 08:00 ET | Quelle: GeneDx

In JAMA Oncology Publication, GeneDx Describes Lower Lifetime Risk of Gastric Cancer Conferred by CDH1

GAITHERSBURG, Md., Aug. 06, 2019 (GLOBE NEWSWIRE) -- GeneDx, Inc., a subsidiary of BioReference Laboratories, Inc., and a recognized leader in genetic and genomic testing, announced the results...
02. Mai 2019 17:05 ET | Quelle: Bio-Reference Laboratories

BioReference Laboratories to Present at ACOG 2019, Demonstrating Commitment to the Research of Hereditary Conditions

Elmwood Park, NJ, May 02, 2019 (GLOBE NEWSWIRE) -- BioReference Laboratories, Inc., an OPKO Health Company, along with its women’s health division GenPath, today announced the presentation of new...